☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
the DCGI
Biocon's ALZUMAb (itolizumab) Receives the DCGI's Approval for Emergency Use to Treat Patients with Moderate to Severe COVID-19
July 13, 2020
Mylan's Remdesivir Lyophilized Powder for Injection Receives the DCGI Accelerated Approval for Restricted Emergency Use in COVID-1...
July 6, 2020
Load more...
Back to Home